Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Patent
1991-03-07
1992-07-28
Daus, Donald G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C07D47504
Patent
active
051342359
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The invention relates to a process for preparing (6S)-folinic acid and its salts, especially calcium, magnesium, potassium and sodium folinate.
Folinic acid is N-(5-formyl-(6R,S)-5,6,7,8-tetrahydro-pteroyl)-L-glutamic acid (5-CHO-(6R,S)-H.sub.4 PteGlu). N-(5-formyl-(6S)-5,6,7,8-tetrahydropteroyl)-L-glutamic acid (5-CHO-(6S)-H4PteGlu) is the citrovorum factor (=growth-promoting factor for leuconostoc citrovorum).
Folinic acid contains 2 asymmetric centers. Also, due to the synthesis of the folinic acid from folic acid, N-(pteroyl)-L-glutamic acid, the optically active C atom contained in the glutamic acid group is present in the L form while the optically active C atom resulting from the hydrogenation of the double bond in the 5,6 position is present in position 6 in the racemic, (6R,S), form. Synthetic folinic acid (=leucovorin) therefore consists of a 1:1 mixture of two diastereomers.
Leucovorin is finding increasing importance as a pharmaceutical preparation for treating megaloblastic, folic-acid-deficiency, anaemia, as an antidote for intensifying the tolerance of folic acid antagonists especially of aminopterin and methotrexate in cancer therapy (leucovorin rescue) and the treatment of autoimmune diseases such as psoriasis and rheumatoid arthritis, and intensifying the tolerance of certain antiparasites, such as trimethoprim-sulphamethoxazole, in chemotherapy.
In the natural state, for example in the liver, folinic acid is found only in the S form. The biochemical action of leucovorin as a folic acid cofactor is based on its content of 5-CHO-(6S)-H.sub.4 PeGlu. On the other hand the inverse (R]form -5-CHO-(6R)-H.sub.4 PteGlu- is barely metabolized and is slowly eliminated through the urine. It is biochemically inactive. J. A. Straw et al, Cancer Research 44, 3114 (1984).
Many attempts have therefore been undertaken to separate 5-formyl-(6R,S)-5,6,7,8-tetrahydro-pteroyl-L-glutamic acid and synthesize 5-formyl-(6S)-5,6,7,8-tetrahydro-pteroyl-L-glutamic acid asymmetrically and isolate the physiologically active form. D. Cosulich et al, J. Amer. Chem. Soc. 74, 4215-16 (1952), U.S. patent Specification 2,688,018 have attempted to accomplish the separation by fractional crystallization of an alkaline-earth salt, for example the calcium or strontium salt, of 5-formyl-(6R,S)-5,6,7,8-tetrahydro-pteroyl)-L-glutamic acid from an aqueous solution. The required separation cannot be realized under the conditions published by B. Cosulich et al. In the crystallization of, for example, the calcium salt of 5-formyl-(6R,S)-5,6,7,8-tetrahydro-pteroyl-L-glutamic acid from water at pH 7-8 the pure (6R,S)-form is always obtained again, which can be shown quantitatively by chromatographic analysis on a chiral HPLC column and by reference to the optical rotation. In this case it is immaterial whether the crude or pure calcium salt of 5-CHO-(6R,S)-H.sub.4 PteGlu is used for the crystallization; the optically pure (6R,S)-form is always recovered. Nor can separation and concentration of the (6S)-form be achieved if the supersaturated aqueous solution of alkaline-earth-(6R,S)-folinate is seeded with authentic alkaline-earth-(6S)-folinate. Until now asymmetric synthesis has therefore remained the only possibility for preparing N-(5-formyl-(6S)-5,6,7,8-tetrahydro-pteroyl)-L-91utamic acid.
The previously known methods for asymmetric synthesis of (6S)-folinic acid are, however, not suitable for the preparation of this compound on a commercial scale. Until the present there have therefore been no commercially viable methods for the preparation of (6S)-folinic acid.
There remains, therefore, the problem of developing a simple, commercially useful and cost-effective method for preparing (6S)-folinic acid and it salts.
SUMMARY OF THE INVENTION
Surprisingly, it was found that during the recrystallization of the alkaline-earth salts of (6R,S)-folinic acid, for example of calcium-, magnesium- or strontium-N-(5-formyl-(6R,S)-5,6,7,8-tetrahydropteroyl)-L-glutamate (=alkaline-earth-(6R,S)-folinate), preferably fr
REFERENCES:
patent: 2688018 (1954-08-01), Cosulich
patent: 4959472 (1990-09-01), Wood et al.
patent: 5006655 (1991-04-01), Mueller et al.
patent: 5010194 (1991-09-01), Mueller et al.
Kanegafuchi, Chem. Abstr. vol. 98 entry 215624r (1983).
Temple et al. Cancer Treat Rep vol. 65 pp. 1117-1119 (1981).
Chem. Abstr. vol. 107 entry 214060w (1987).
Merck Index 10th Edition (1983) entry 4111.
J. Feeney, Biochemistry, vol. 20, pp. 1837-1842 (1981).
Cosulich, Jour. Am. Chem. Soc. vol. 74, pp. 4215-4216 (1952).
G. Mozzi et al., "Stabilita del calcio folinato in soluzioni acquose in funzione del pH e della temperatura", Belletino Chemico Farmaceutico, 125 (12), 1986, pp. 424-428.
Temple et al., Journal of Medicinal Chemistry, 1979, vol. 22, No. 6 pp. 731-734.
Folates and Pterins, vol. 1, Chemistry and Biochemistry of Folates, pp. xiii and 99 (1984).
Kalbermattan et al., Helvitica Chemica Acta, vol. 64, Fasc. 8, Nr. 266, p. 2627 (1981).
The Journal of Biological Chemistry, vol. 238, No. 4, pp. 1498-1500 (Apr. 1963).
Rees et al., Tetrahedron, vol. 42, No. 1, pp. 117-136 (1986).
White et al., The Journal of Biological Chemistry, vol. 253, No. 1, pp. 242-245 (Jan. 10, 1978).
Fachlexikon ABC Chemie, Stereoisomeric, p. 1077 (1987).
Analytical Biochemistry 22, 166-177 (1968).
Choi et al., Analytical Biochemistry 168, 398-404 (1988).
Fontecilla-Camps, J. C. et al., Chemistry and Biology of Pteridines p. 235, Elsevier/North-Holland, N.Y. (1979).
Fontecilla-CXamps et al., Journal of American Chemical Society, vol. 101:20, Sep. 26, 1979 pp. 6114-6115.
Rees, L. et al. J. Chem. Soc., Chem. Commun., A Simple and Effective Method for the Preparation of the 6(R)- and 6(S)--Diastereoisomers, pp. 470-472, (1987).
Russian Article: Kaplan, E. Y. et al., Biologiceskie Nauki, vol. 7, 1987, pp. 33-37.
Conti Josef
Mueller Hans R.
Muerdel Gunter
Ulmann Martin
Daus Donald G.
Eprova A.G.
LandOfFree
Process for separating folinic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for separating folinic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for separating folinic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1687975